Tolvaptan-induced isolated elevation of bilirubin in a patient with Gilbert syndrome

Tolvaptan is the current standard of treatment for autosomal dominant polycystic kidney disease. It operates by acting on V2 receptors and blocks vasopressin interactions, causing a reduction in the rate of renal cyst growth and preserving kidney function. The current known risks of tolvaptan involv...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Matthew, Yanny, Beshoy T, Truong, Tai LD, Zhao, Hongyu, Hanna, Ramy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154994/
https://www.ncbi.nlm.nih.gov/pubmed/37151737
http://dx.doi.org/10.1177/2050313X231169841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154994/
https://www.ncbi.nlm.nih.gov/pubmed/37151737
http://dx.doi.org/10.1177/2050313X231169841

Ejemplares similares